Drug Database
Back to search

Italy· 045442023

HOMERDELIK

A amoxicillin und beta-lactamase-inhibitor product containing amoxicillina + acido clavulanico, registered in Italy by SO.SE.PHARM S.R.L., on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC J01CR02

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedHOMERDELIKATCJ01CR02REGISTER NO.045442023PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about amoxicillina + acido clavulanicoAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Amoxicillin und beta-lactamase-inhibitor is registered in 13 of 19 countries.

Countries holding a registration under ATC J01CR02 (amoxicillin und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 9 of them publish a price we can compare per daily dose
Search amoxicillin und beta-lactamase-inhibitor products by name

Amoxicillin und beta-lactamase-inhibitor · ATC J01CR02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of amoxicillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.28 in Italy to $5.60 in Switzerland — a ×4.4 gap.

  • Italy: $1.28 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Amoxicillin und beta-lactamase-inhibitor · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.60
  • ES Spain$4.65
  • CZ Czechia$1.42
  • IT Italy$1.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Amoxicillina + Acido clavulanico
Manufacturer
SO.SE.PHARM S.R.L.
Country
Italy (IT)
ATC code
J01CR02
ATC class
Amoxicillin und Beta-Lactamase-Inhibitor
Defined daily dose
1.5 g, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    045442023
    "400 MG/57 MG/5 ML POLVERE PER SOSPENSIONE ORALE GUSTO FRAGOLA" 1 FLACONE IN VETRO DA 140 ML
    EUR 13.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for amoxicillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check amoxicillin und beta-lactamase-inhibitor against other medicinesHow interaction checks work

Amoxicillin und beta-lactamase-inhibitor · interactions on record

24 records

  • 4 severe
  • 17 moderate

Most severe, free to view

  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • TeriflunomideL04AK02severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amoxicillin und beta-lactamase-inhibitor in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amoxicillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Amcladoz, Amclavu
  • Belgium · Amoclane, Amoclaneeg
  • Bulgaria · Amoksiklav Es, Aмоксигамма
  • Cyprus · Augmentin, Augmentin Es
  • Czechia · Amoksiklav, Amoxicillin/Clavulanic Acid Aptapharma
  • Germany · Amoclan, Amoclav
  • Denmark · Amoxicillin/Clavulansyre Aurobindo, Baxumil
  • Estonia · Amoksiklav, Amoxicillin/Clavulanic Acid Auxilia
  • Spain · Amoxicilina / Ácido Clavulánico Pensa Pharma, Amoxicilina/Ácido Clavulánico Almus
  • Finland · Amorion Comp, Amoxicillin/Clavulanic Acid Bioglan
  • France · Amoxicillin / Clavulanic Acid Reig Jofre, Amoxicillin/Acide Clavulanique Zydus France
  • United Kingdom (Northern Ireland) · Augmentin, Augmentin Duo
  • Greece · Augmentin, Augmentin Mf (Γεύση Φρούτων)
  • Croatia · Amoksicilin/Klavulanska Kiselina Antibiotice, Amoksicilin/Klavulanska Kiselina Aptapharma
  • Hungary · Aksolin, Aktil
  • Ireland · Amoclav, Amoxicillin/Clavulanic Acid Krka
  • Iceland · Amoxicillin/Clavulanic Acid Normon, Spectracillin
  • Lithuania · Amoksiklav, Amoxicillin/Clavulanic Acid Antibiotice
  • Luxembourg · Amoclane, Amoxiclav
  • Latvia · Amoksiklav, Amoxicillin/Clavulanic Acid
  • Malta · Amoxi-Clavulan, Amoxicillin/Clavulanic Acid Aptapharma
  • Netherlands · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicilline/Clavulaanzuur
  • Norway · Augmentin, Augmentin Blandet Fruktsmak
  • Poland · Amoclan, Amoksiklav
  • Portugal · Agmalife, Agmalife Bid
  • Romania · Amoksiklav, Amoksiklav Quicktab
  • Sweden · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicillin/Clavulanic Acid Bb
  • Slovenia · Amoksicilin/Klavulanska Kislina Antibiotice, Amoksicilin/Klavulanska Kislina Aptapharma
  • Slovakia · Amoksiklav, Amoksiklav 2 X

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bfafe754-0a8c-4306-95cb-eb1da5cbbab5
GET /v1/drugs/bfafe754-0a8c-4306-95cb-eb1da5cbbab5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"400 MG/57 MG/5 ML POLVERE PER SOSPENSIONE ORALE GUSTO FRAGOLA\" 1 FLACONE IN VETRO DA 140 ML",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Amoxicillina + Acido clavulanico",
  "reference_pack": "140 ML (80+11,4) MG/ML - USO ORALE",
  "public_price_eur": 13.2,
  "ssn_reference_price_eur": 13.2
}
API referenceMCP serverPlans

See everything about amoxicillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console